Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue 2, 1997, Pages 125-132

  Wilairatana, P ^a   Kyle, D E ^b   Looareesuwan, S ^a   Chinwongprom, K ^a   Amradee, S ^a   White, N J ^c   Watkins, W M ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BIGUANIDE DERIVATIVE; CHLOROQUINE; CHLORPROGUANIL; CYCLOGUANIL; DAPSONE; MEFLOQUINE; PROGUANIL;

ADOLESCENT; ADULT; AFRICA; ARTICLE; ASIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; THAILAND;

EID: 0030972041     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1997.11813121     Document Type: Article

References (26)

1. BUNNAG, D., VIRAVAN, C., KARBWANG, J., LOOAREESUWAN, S., CHITTAMAS, S., HARINASUTA, T., SERVILLE, P. & HORTON, J. (1993). Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health, 24, 43-48.
2. CHAUDHURI, R. N., CHAKRAVARTY, N. K., CHAUDHURI, M. N. & JANARDAN, P. (1952). Chemotherapy and chemoprophylaxis of malaria: clinical trials in 500 cases and mass prophylaxis in a hyperendemic area. British Medical Journal, i, 568-574.
3. EDESON, J. F. B. & FIELD, J. W. (1950). Proguanil-resistant falciparum malaria in Malaya. British Medical Journal, i, 147-151.
4. EDSTEIN, E. D., SHANKS, G. D., TEJA-ISAVADHARM, P., RIECKMANN, K. H. & WEBSTER, H. K. (1994). Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. British Journal of Clinical Pharmacology, 37, 67-70.
5. HELSBY, N. A., WARD, S. A., EDWARDS, G., HOWELLS, R. E. & BRECKENRIDGE, A. M. (1990). The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. British Journal of Clinical Pharmacology, 30, 593-598.
6. HORAI, Y., NAKANO, M., ISHIZAKI, T., ISHIKAWA, K., ZHOU, H. H., ZHOU, B. J., LIAO, C. L. & ZHANG, L. M. (1989). Metoprolol and mephenytoin oxidation polymorphism in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clinical Pharmacology and Therapeutics, 46, 198-207.
7. KARWACKI, J. J., SHANKS, G. D., SURIYAMONGKOL, V. & WATANASOOK, C. (1991). Proguanil/sulfamethoxazole malaria chemoprophylaxis on the Thai-Cambodian border. Southeast Asian Journal of Tropical Medicine and Public Health, 22, 77-80.
8. LIMSOMWONG, N., PANG, L. W. & SINGHARAJ, P. (1988). Malaria prophylaxis with proguanil in children living in an malaria-endemic area. American Journal of Tropical Medicine and Hygiene, 38, 231-236.
9. LOOAREESUWAN, S., HARINASUTA, T. & CHONGSUPHAJAISIDDHI, T. (1992a). Drug resistant malaria with special reference to Thailand. Southeast Asian Journal of Tropical Medicine and Public Health, 23, 621-634.
10. LOOAREESUWAN, S., WILAIRATANA, P., VANIJANONTA, S., KYLE, D. & WEBSTER, K. (1992b). Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet, i, 369.
11. LOOAREESUWAN, S., VANIJANONTA, S., VIRAVAN, C., WILAIRATANA, P., CHAROENLARP, P., LASSERRE, R., CANFIELD, C., KYLE, D. E. & WEBSTER, H. K. (1994). Randomised trial of mefloquine-tetracycline and quinine-tetracycline for acute uncomplicated falciparum malaria. Acta Tropica, 57, 47-53.
12. LOOAREESUWAN, S., VIRAVAN, C., WEBSTER, H. K., KYLE, D., HUTCHINSON, D. B. & CANFIELD, C. J. (1996). Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54, 62-66.
13. MBERU, E. K., WANSOR, T., SATO, H., NISHIKAWA, Y. & WATKINS, W. M. (1996). Japanese poor metabolisers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough. Transactions of the Royal Society of Tropical Medicine and Hygiene, in press.
14. MILHOUS, W. K., WEATHERLY, N. F., BOWDRE, J. H. & DESJARDINS, R. E. (1985). In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrobial Agents and Chemotherapy, 27, 525-530.
15. NOSTEN, F., TER KUILE, F., CHONGSUPHAJAISIDDHI, T., LUXEMBURGER, C., WEBSTER, H. K., EDSTEIN, M., PHAIPUN, L., LAY THEW, K. & WHITE, N. J. (1991). Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet, i, 1140-1143.
16. NOSTEN, F., TER KUILE, F. O., LUXEMBURGER, C., WOODROW, C., KYLE, D. E., CHONGSUPHAJAISIDDHI, T. & WHITE, N. J. (1993). Cardiac effects of antimalarial treatment with halofantrine. Lancet, i, 1054-1056
17. PANG, L. W., LIMSOMWONG, N., SINGHARAT, P. & CANFIELD, C. J. (1988). Successful use of proguanil-sulphonamide in malaria chemoprophylaxis. Bulletin of the World Health Organization, 67, 57-58.
18. PETERSON, D. S., MILHOUS, W. K. & WELLEMS, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 87, 3018-3022.
19. SMITH, C. C., IHRIG, J. & MENNE, R. (1961). Antimalarial activity and metabolism of biguanides. 1. Metabolism of chloroguanide and chloroguanide triazine in rhesus monkeys and man. American Journal of Tropical Medicine and Hygiene, 10, 694-703.
20. TER KUILE, F. O., DOLAN, G., NOSTEN, F., EDSTEIN, M., LUXEMBURGER, C., PHAIPUN, L., CHONGSUPHAJAISIDDHI, T., WEBSTER, H. K. & WHITE, N. J. (1993). Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet, i, 1044-1049.
21. WARD, S. A., WATKINS, W. M., MBERU, E., SAUNDERS, J. E., KOECH, D. K., GILLES, H. M., HOWELLS, R. E. & BRECKENRIDGE, A. M. (1989). Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. British Journal of Clinical Pharmacology, 27, 781-787.
22. WATKINS, W. M., HOWELLS, R. E., BRANDLING-BENNETT, A. D. & KOECH, D. K. (1987). Susceptibility of Plasmodium falciparum isolates from Jilore, Kenya, to antimalarial drugs. American Journal of Tropical Medicine and Hygiene, 37, 445-451.
23. WATKINS, W. M., BRANDLING-BENNETT, A. D., NEVILLE, C. G., CARTER, J. Y., BORIGA, D. A., HOWELLS, R. E. & KOECH, D. K. (1988). Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 398-403.
24. WEBSTER, H. K., BOUDREAU, E. F., PAVANAND, K., YONGVANITHCHIT, K. & PANG, L. W. (1985). Anti-malarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. American Journal of Tropical Medicine and Hygiene 34, 228-235.
25. WORLD HEALTH ORGANIZATION (1984). Advances in Malaria Chemotherapy. Technical Report Series No. 529. Geneva: WHO.
26. WORLD HEALTH ORGANIZATION (1990). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84 (Suppl. 2), 1-65.